#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12574	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2154	577.0	0	.	n	.	0	C451T	SNP	451	451	C	657	657	T	750	T,C	718,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12574	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2154	577.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1390	1390	C	665	C,A,T	640,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23220	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3414	673.0	0	.	n	.	0	T695C	SNP	695	695	T	902	902	C	734	C,T	703,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23220	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3414	673.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2178	2178	C	707	C	673	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23220	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3414	673.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2252	2252	A	721	A	699	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23220	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3414	673.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2804	2804	C	681	C	660	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23220	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3414	673.0	0	HET	.	.	.	A1638G	.	1638	1638	A	1845	1845	A	742	A,G	550,160	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	14	blaTEM	861	421	99.76	blaTEM.l15.c30.ctg.1	421	2.4	0	.	p	.	0	M180T	NONSYN	538	540	ATG	220	222	ACG	4;4;5	A;C;G	4;4;5	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1520	folP	855	855	100.0	folP.l15.c4.ctg.1	1500	100.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1024	1026	AGC	159;159;161	A;G;C	152;151;152	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4702	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3348	139.2	1	SNP	p	S91F	1	.	.	271	273	TTC	583	585	TTC	169;168;170	T;T;C	163;161;160	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4702	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3348	139.2	1	SNP	p	G95N	0	.	.	283	285	GGC	595	597	GGC	163;164;162	G;G;C	155;156;156	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4702	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3348	139.2	1	SNP	p	D95G	1	.	.	283	285	GGC	595	597	GGC	163;164;162	G;G;C	155;156;156	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1314	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1432	90.6	1	SNP	p	G45D	0	.	.	133	135	GGC	593	595	GGC	136;134;134	G;G;C	132;131;131	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	660	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1012	64.8	0	.	n	.	0	A197.	DEL	197	197	A	594	594	A	158	A	155	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4260	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2954	143.3	1	SNP	p	D86N	0	.	.	256	258	GAC	611	613	GAC	180;181;182	G;A,C;C	169;167,1;173	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4260	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2954	143.3	1	SNP	p	S87R	1	.	.	259	261	CGT	614	616	CGT	182;181;180	C;G;T,C	171;170;159,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4260	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2954	143.3	1	SNP	p	R87W	0	.	.	259	261	CGT	614	616	CGT	182;181;180	C;G;T,C	171;170;159,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4260	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2954	143.3	1	SNP	p	R87I	0	.	.	259	261	CGT	614	616	CGT	182;181;180	C;G;T,C	171;170;159,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4260	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2954	143.3	1	SNP	p	S88P	0	.	.	262	264	TCC	617	619	TCC	178;177;177	T;C;C	164;167;166	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3392	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2496	134.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1427	1429	GGC	160;160;159	G;G;C	157;155;150	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.35.001	penA.35.001	1	1	27	3146	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2373	131.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1263	1265	GCC	179;177;179	G;C;C	171;170;170	penA.35.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3146	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2373	131.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1266	1268	ATG	179;179;176	A;T;G	172;171;170	penA.35.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3146	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2373	131.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1278	1280	ACC	181;182;182	A;C;C	166;177;174	penA.35.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3146	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2373	131.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1278	1280	ACC	181;182;182	A;C;C	166;177;174	penA.35.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3146	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2373	131.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1779	1781	ACC	147;149;148	A;C;C	138;146;145	penA.35.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3146	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2373	131.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1833	1835	GCG	150;147;146	G;C,G;G	140;126,3;133	penA.35.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3146	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2373	131.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1833	1835	GCG	150;147;146	G;C,G;G	140;126,3;133	penA.35.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3146	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2373	131.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1956	1958	GGT	147;145;141	G;G;T	136;134;130	penA.35.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3146	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2373	131.4	1	SNP	p	G545S	0	.	.	1633	1635	GGC	1965	1967	GGC	135;133;133	G;G;C,A	124;122;123,1	penA.35.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3146	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2373	131.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1983	1985	CCG	97;98;99	C,G;C,G;G	86,2;84,2;80	penA.35.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4722	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3160	147.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1619	1621	CCG	137;137;136	C,T;C,T,G;G	125,1;133,1,1;124	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2036	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1590	126.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	445	445	C	129	C	122	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2418	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1490	159.3	0	.	p	.	0	I45V	NONSYN	133	135	ATT	467	469	GTT	177;175;175	G;T;T	172;169;172	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2418	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1490	159.3	0	.	p	.	0	G46S	NONSYN	136	138	GGC	470	472	AGC	175;176;178	A;G;C	172;170;171	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2418	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1490	159.3	0	.	p	.	0	G48A	NONSYN	142	144	GGA	476	478	GCA	179;180;187	G;C;A	170;167;177	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2418	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1490	159.3	1	SNP	p	G120K	1	.	.	358	360	AAG	692	694	AAG	197;196;194	A,C;A;G	187,1;187;179	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2418	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1490	159.3	1	SNP	p	N121D	0	.	.	361	363	AAC	695	697	AAC	193;192;192	A;A,C;C,A	189;185,1;180,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2418	porB1b	1038	1038	99.71	porB1b.l15.c30.ctg.1	1490	159.3	1	SNP	p	A121N	1	.	.	361	363	AAC	695	697	AAC	193;192;192	A;A,C;C,A	189;185,1;180,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8544	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4914	172.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	958	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	993	95.6	1	SNP	p	V57M	1	.	.	169	171	ATG	494	496	ATG	191;192;190	A;T;G	184;186;183	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
